← Zurück zum Wiki

Quellenregister

Alle wissenschaftlichen Quellen, auf die unsere Fachartikel verweisen – nach Herausgeber gruppiert.

Neuer Bereich

Jetzt verfügbar: das Schädlings-Lexikon mit Bildkarten, Kategorien, Risikobewertungen und Gegenmaßnahmen.

Schädlings-Lexikon öffnen

Gesamt

71

Quellen

Automatisch synchronisiert

22

synchronisiert

Redaktionell geprüft

49

geprüfte Einträge

Publisher

65

verteilt

Redaktioneller Hinweis: Dieses Register dient als strukturierte Orientierung für die evidenzbasierte Vertiefung. Vor operativen oder regulatorischen Entscheidungen sollten stets die aktuellen Originaldokumente geprüft werden.

71 Treffer in 65 Publisher-Gruppen

Drug and Alcohol Dependence

4 Quellen
  1. Comparative Pharmacokinetics: Inhalation vs. Oral vs. Edible Cannabinoid Administration

    Drug and Alcohol Dependence (2024)

    Redaktionell geprüft

    ID: drug-alcohol-dependence-consumption-methods

    Zur Quelle
  2. Relations between depression and cannabis use among college students in evolving state cannabis policy environments

    Drug and Alcohol Dependence (2026)

    Automatisch synchronisiert

    ID: auto-10-1016-j-drugalcdep-2026-113127

    DOI: 10.1016/j.drugalcdep.2026.113127

    Zur Quelle
  3. Cannabis legalization and early adolescent expectancies: Findings from the adolescent brain cognitive development study

    Drug and Alcohol Dependence (2026)

    Automatisch synchronisiert

    ID: auto-10-1016-j-drugalcdep-2026-113138

    DOI: 10.1016/j.drugalcdep.2026.113138

    Zur Quelle
  4. Cannabis retail environment and treatment for cannabis use disorder

    Drug and Alcohol Dependence (2026)

    Automatisch synchronisiert

    ID: auto-10-1016-j-drugalcdep-2026-113096

    DOI: 10.1016/j.drugalcdep.2026.113096

    Zur Quelle

European Medicines Agency

2 Quellen
  1. EMA Guideline on Good Manufacturing Practice (GMP)

    European Medicines Agency (2023)

    Redaktionell geprüft

    ID: ema-good-manufacturing-practice

    Zur Quelle
  2. Using Real-World Evidence in Medicines Evaluation

    European Medicines Agency (2024)

    Redaktionell geprüft

    ID: ema-real-world-evidence-2024

    Zur Quelle

Sleep Medicine: X

2 Quellen
  1. Integrative therapies for chronic insomnia: A randomized controlled trial of a traditional Thai herbal remedy and Cannabis sativa oil

    Sleep Medicine: X (2026)

    Automatisch synchronisiert

    ID: auto-10-1016-j-sleepx-2026-100180

    DOI: 10.1016/j.sleepx.2026.100180

    Zur Quelle
  2. Integrative therapies for chronic insomnia: A randomized controlled trial of a traditional Thai Herbal Remedy and Cannabis sativa oil

    Sleep Medicine: X (2026)

    Automatisch synchronisiert

    ID: auto-10-1016-j-sleepx-2026-100173

    DOI: 10.1016/j.sleepx.2026.100173

    Zur Quelle

Addictive Behaviors Reports

2 Quellen
  1. Associations of cannabis, alcohol, and tobacco use combinations with sleep health

    Addictive Behaviors Reports (2026)

    Automatisch synchronisiert

    ID: auto-10-1016-j-abrep-2026-100680

    DOI: 10.1016/j.abrep.2026.100680

    Zur Quelle
  2. Consumption patterns and withdrawal symptoms in dual cannabis-tobacco users in Spain: Cross-sectional study

    Addictive Behaviors Reports (2026)

    Automatisch synchronisiert

    ID: auto-10-1016-j-abrep-2025-100656

    DOI: 10.1016/j.abrep.2025.100656

    Zur Quelle

World Health Organization

1 Quellen
  1. Cannabis and Cannabis-Related Substances: Public Health Overview

    World Health Organization (2024)

    Redaktionell geprüft

    ID: who-cannabis-2024

    Zur Quelle

UNODC

1 Quellen
  1. World Drug Report 2025: Cannabis Monitoring

    UNODC (2025)

    Redaktionell geprüft

    ID: unodc-world-drug-report-2025

    Zur Quelle

EUDA (European Monitoring Centre for Drugs and Drug Addiction)

1 Quellen
  1. European Drug Report 2025: Cannabis Profiles and Market Monitoring

    EUDA (European Monitoring Centre for Drugs and Drug Addiction) (2025)

    Redaktionell geprüft

    ID: emcdda-cannabis-profiles-2025

    Zur Quelle

JAMA Network

1 Quellen
  1. Cannabis and Cannabinoids: Clinical Evidence and Meta-Analyses

    JAMA Network (2024)

    Redaktionell geprüft

    ID: jama-cannabinoid-evidence-2024

    Zur Quelle

The Lancet Neurology

1 Quellen
  1. Cannabis for Neurological Disorders: A Systematic Review

    The Lancet Neurology (2024)

    Redaktionell geprüft

    ID: lancet-cannabis-neurology

    Zur Quelle

Nature Neuroscience

1 Quellen
  1. CBD and Anxiety Disorders: Pharmacological Mechanisms and Evidence

    Nature Neuroscience (2023)

    Redaktionell geprüft

    ID: nature-neuroscience-cbd-anxiety

    Zur Quelle

Addiction

1 Quellen
  1. Cannabis Use Disorder and THC Dependence: Clinical Guidelines

    Addiction (2024)

    Redaktionell geprüft

    ID: addiction-thc-dependence-2024

    Zur Quelle

Neuropsychology

1 Quellen
  1. Acute and Chronic Effects of THC on Cognitive Function

    Neuropsychology (2023)

    Redaktionell geprüft

    ID: neuropsychology-cognitive-effects

    Zur Quelle

Pain

1 Quellen
  1. Cannabinoids in Pain Management: Evidence and Clinical Applications

    Pain (2024)

    Redaktionell geprüft

    ID: pain-cannabinoids-review

    Zur Quelle

AOAC International

1 Quellen
  1. AOAC Official Methods of Analysis: Cannabis Testing Protocols

    AOAC International (2024)

    Redaktionell geprüft

    ID: aoac-lab-methods-2024

    Zur Quelle

ISO

1 Quellen
  1. ISO/IEC 17025: General Requirements for Testing Laboratories

    ISO (2017)

    Redaktionell geprüft

    ID: iso17025-testing-labs

    Zur Quelle

ASTM International

1 Quellen
  1. ASTM D37 Committee Standards on Cannabis

    ASTM International (2025)

    Redaktionell geprüft

    ID: astm-d37-cannabis

    Zur Quelle

Journal of Chromatography A

1 Quellen
  1. Gas and Liquid Chromatography Methods for Cannabinoid Analysis

    Journal of Chromatography A (2024)

    Redaktionell geprüft

    ID: journal-chromatography-cannabinoids

    Zur Quelle

Analytical Chemistry

1 Quellen
  1. Terpene Profiling and Quantification in Cannabis

    Analytical Chemistry (2023)

    Redaktionell geprüft

    ID: analytical-chemistry-terpen-profiling

    Zur Quelle

Journal of Food Chemistry

1 Quellen
  1. Contaminant Detection and Analysis in Cannabis Products

    Journal of Food Chemistry (2024)

    Redaktionell geprüft

    ID: journal-food-chemistry-contaminants

    Zur Quelle

Nature Portfolio

1 Quellen
  1. Postharvest Stability, Water Activity and Terpene Retention

    Nature Portfolio (2024)

    Redaktionell geprüft

    ID: nature-postharvest-terpenes

    Zur Quelle

Phytochemistry

1 Quellen
  1. Terpenoid Biosynthesis and Cannabis Flavor Chemistry

    Phytochemistry (2023)

    Redaktionell geprüft

    ID: phytochemistry-cannabinoid-terpen-profile

    Zur Quelle

Flavour and Fragrance Journal

1 Quellen
  1. Aroma Chemistry and Sensory Evaluation of Cannabis Products

    Flavour and Fragrance Journal (2024)

    Redaktionell geprüft

    ID: flavour-fragrance-journal-cannabis-aroma

    Zur Quelle

Horticulture Research

1 Quellen
  1. Modern Cultivation Techniques and Environmental Control for Cannabis

    Horticulture Research (2024)

    Redaktionell geprüft

    ID: horticulture-research-cannabis-cultivation

    Zur Quelle

Plant Physiology

1 Quellen
  1. Vapor Pressure Deficit and Transpiration in Controlled Environments

    Plant Physiology (2023)

    Redaktionell geprüft

    ID: plant-physiology-vpd-transpiration

    Zur Quelle

Genetics

1 Quellen
  1. Genomic Analysis of Cannabis: Trait Heritability and Phenotype Selection

    Genetics (2024)

    Redaktionell geprüft

    ID: genetics-heritable-traits-cannabis

    Zur Quelle

Postharvest Biology and Technology

1 Quellen
  1. Curing and Drying: Effects on Secondary Metabolism and Quality

    Postharvest Biology and Technology (2024)

    Redaktionell geprüft

    ID: postharvest-biology-technology-curing

    Zur Quelle

Pharmaceutical Research

1 Quellen
  1. Bioavailability and Pharmacokinetics of Cannabinoids

    Pharmaceutical Research (2023)

    Redaktionell geprüft

    ID: pharmaceutical-research-bioavailability

    Zur Quelle

Clinical Pharmacology & Therapeutics

1 Quellen
  1. First-Pass Metabolism and Bioavailability of Oral Cannabis Products

    Clinical Pharmacology & Therapeutics (2024)

    Redaktionell geprüft

    ID: clinical-pharmacology-thc-cbd-kinetics

    Zur Quelle

Applied Microbiology and Biotechnology

1 Quellen
  1. Fungal Contamination and Safety in Cannabis Products

    Applied Microbiology and Biotechnology (2024)

    Redaktionell geprüft

    ID: applied-microbiology-fungal-contamination

    Zur Quelle

Food Control

1 Quellen
  1. Water Activity, Microbial Stability and Shelf-Life Extension

    Food Control (2023)

    Redaktionell geprüft

    ID: food-control-water-activity-microbiology

    Zur Quelle

Journal of Food Protection

1 Quellen
  1. Plant Growth Regulators and Pesticide Residues in Cannabis

    Journal of Food Protection (2024)

    Redaktionell geprüft

    ID: journal-food-protection-pgr-pesticides

    Zur Quelle

Toxicology

1 Quellen
  1. Heavy Metal Accumulation in Cannabis and Risk Assessment

    Toxicology (2023)

    Redaktionell geprüft

    ID: toxicology-heavy-metals-cannabis

    Zur Quelle

Codex Alimentarius Commission

1 Quellen
  1. General Principles of Food Hygiene

    Codex Alimentarius Commission (2022)

    Redaktionell geprüft

    ID: codex-food-hygiene-2022

    Zur Quelle

European Chemicals Agency (ECHA)

1 Quellen
  1. Chemical Safety and Risk Communication in Food Supply

    European Chemicals Agency (ECHA) (2024)

    Redaktionell geprüft

    ID: echa-chemical-safety-2024

    Zur Quelle

European Commission

1 Quellen
  1. EU Guidelines for Quality Overall Summary (EudraLex Volumes)

    European Commission (2025)

    Redaktionell geprüft

    ID: gmp-eu-guidelines-2025

    Zur Quelle

Bundesinstitut fuer Arzneimittel (BfArM)

1 Quellen
  1. BfArM Cannabis Cultivation and Quality Guidelines

    Bundesinstitut fuer Arzneimittel (BfArM) (2024)

    Redaktionell geprüft

    ID: bfarm-german-cannabis-guidelines

    Zur Quelle

Swissmedic

1 Quellen
  1. Swissmedic Guidelines for Cannabis Product Authorization

    Swissmedic (2024)

    Redaktionell geprüft

    ID: swissmedic-cannabis-requirements

    Zur Quelle

Austrian Agency for Health and Food Safety

1 Quellen
  1. AGES Cannabis Quality and Testing Standards (Austria)

    Austrian Agency for Health and Food Safety (2024)

    Redaktionell geprüft

    ID: ages-austria-cannabis-standards

    Zur Quelle

U.S. Food and Drug Administration

1 Quellen
  1. FDA Perspective on Cannabis-Derived Products

    U.S. Food and Drug Administration (2024)

    Redaktionell geprüft

    ID: fda-cannabis-guidance-2024

    Zur Quelle

Cochrane Library

1 Quellen
  1. Cochrane Systematic Review: Cannabinoids for Medical Use

    Cochrane Library (2024)

    Redaktionell geprüft

    ID: cochrane-cannabis-review-2024

    Zur Quelle

Pharmacological Reviews

1 Quellen
  1. Endocannabinoid System and CB1/CB2 Receptor Pharmacology

    Pharmacological Reviews (2023)

    Redaktionell geprüft

    ID: cannabinoid-receptor-pharmacology

    Zur Quelle

Nutrients

1 Quellen
  1. Lipid Formulation Effects on Cannabinoid Absorption in Edibles

    Nutrients (2024)

    Redaktionell geprüft

    ID: nutritional-bioavailability-edibles

    Zur Quelle

New England Journal of Medicine

1 Quellen
  1. Cannabis and Cannabinoids in Clinical Medicine: Therapeutic Evidence and Indications

    New England Journal of Medicine (2024)

    Redaktionell geprüft

    ID: nejm-cannabis-evidence-2024

    Zur Quelle

BMJ

1 Quellen
  1. Cannabis: Weighing Benefits and Harms in Clinical and Public Health Contexts

    BMJ (2024)

    Redaktionell geprüft

    ID: bmj-cannabis-harms-benefits-2024

    Zur Quelle

Frontiers in Pharmacology

1 Quellen
  1. Cannabinoid Pharmacology: Mechanisms, Drug Interactions and Therapeutic Windows

    Frontiers in Pharmacology (2024)

    Redaktionell geprüft

    ID: frontiers-pharmacology-cannabinoids-2024

    Zur Quelle

Harm Reduction Journal

1 Quellen
  1. Cannabis Harm Reduction: Strategies, Evidence and Policy Implications

    Harm Reduction Journal (2024)

    Redaktionell geprüft

    ID: harm-reduction-cannabis-policy-2024

    Zur Quelle

Journal of Psychoactive Drugs

1 Quellen
  1. Cannabis Use Patterns, Motives and Health Outcomes: A Review of Current Research

    Journal of Psychoactive Drugs (2024)

    Redaktionell geprüft

    ID: journal-psychoactive-drugs-cannabis-2024

    Zur Quelle

Cannabis & Cannabinoid Research

1 Quellen
  1. Cannabis and Cannabinoid Research: Peer-Reviewed Science for Clinical and Policy Applications

    Cannabis & Cannabinoid Research (2024)

    Redaktionell geprüft

    ID: cannabis-cannabinoid-research-curated

    Zur Quelle

Journal of Psychopharmacology

1 Quellen
  1. Psychopharmacology of Cannabis and Cannabinoids: Reward, Cognition and Dependence

    Journal of Psychopharmacology (2024)

    Redaktionell geprüft

    ID: j-psychopharmacology-cannabis-2024

    Zur Quelle

British Journal of Pharmacology

1 Quellen
  1. Cannabinoid Receptor Pharmacology: Agonists, Antagonists and Allosteric Modulators

    British Journal of Pharmacology (2024)

    Redaktionell geprüft

    ID: british-j-pharmacology-cannab-2024

    Zur Quelle

Regulatory Toxicology and Pharmacology

1 Quellen
  1. Preclinical evidence of cannabis-induced oxidative stress: A systematic review and meta-analysis

    Regulatory Toxicology and Pharmacology (2026)

    Automatisch synchronisiert

    ID: auto-10-1016-j-yrtph-2026-106067

    DOI: 10.1016/j.yrtph.2026.106067

    Zur Quelle

Brain, Behavior, and Immunity

1 Quellen
  1. Regular cannabinoid use and inflammatory biomarkers: Systematic review and hierarchical meta-analysis

    Brain, Behavior, and Immunity (2026)

    Automatisch synchronisiert

    ID: auto-10-1016-j-bbi-2026-106517

    DOI: 10.1016/j.bbi.2026.106517

    Zur Quelle

International Journal of Drug Policy

1 Quellen
  1. Nonmedical cannabis legalization and adolescent inpatient cannabis use disorder, 2008–2020: A quasi-experimental analysis

    International Journal of Drug Policy (2026)

    Automatisch synchronisiert

    ID: auto-10-1016-j-drugpo-2026-105222

    DOI: 10.1016/j.drugpo.2026.105222

    Zur Quelle

Journal of Chromatography Open

1 Quellen
  1. An alternative easy method for the analysis of volatile compounds from lipid matrices: analysis of terpenes and terpenoids in medical-grade Cannabis sativa L. inflorescences in macerated oils

    Journal of Chromatography Open (2026)

    Automatisch synchronisiert

    ID: auto-10-1016-j-jcoa-2026-100316

    DOI: 10.1016/j.jcoa.2026.100316

    Zur Quelle

Neuropharmacology

1 Quellen
  1. Assessment of high-efficacy agonism in synthetic cannabinoid receptor agonists containing l-tert-leucinate

    Neuropharmacology (2026)

    Automatisch synchronisiert

    ID: auto-10-1016-j-neuropharm-2026-110878

    DOI: 10.1016/j.neuropharm.2026.110878

    Zur Quelle

Contemporary Clinical Trials

1 Quellen
  1. An adapted brief negotiation interview for alcohol and cannabis use among assault-injured emerging adults: A randomized pilot trial protocol

    Contemporary Clinical Trials (2026)

    Automatisch synchronisiert

    ID: auto-10-1016-j-cct-2026-108287

    DOI: 10.1016/j.cct.2026.108287

    Zur Quelle

Journal of Substance Use and Addiction Treatment

1 Quellen
  1. Socioeconomic outcomes following outpatient treatment for alcohol, cannabis, and gambling disorder in Greenland: Changes in income, employment, and welfare utilization

    Journal of Substance Use and Addiction Treatment (2026)

    Automatisch synchronisiert

    ID: auto-10-1016-j-josat-2026-209943

    DOI: 10.1016/j.josat.2026.209943

    Zur Quelle

American Journal of Medicine Open

1 Quellen
  1. Risk of Heart Failure-related Events in Patients Exposed to Medical Cannabis: A Longitudinal Cohort Study

    American Journal of Medicine Open (2026)

    Automatisch synchronisiert

    ID: auto-10-1016-j-ajmo-2025-100120

    DOI: 10.1016/j.ajmo.2025.100120

    Zur Quelle

International Journal of Industrial Organization

1 Quellen
  1. Legalization and innovation in the cannabis market

    International Journal of Industrial Organization (2026)

    Automatisch synchronisiert

    ID: auto-10-1016-j-ijindorg-2026-103272

    DOI: 10.1016/j.ijindorg.2026.103272

    Zur Quelle

European Neuropsychopharmacology

1 Quellen
  1. Personality, not cognition, distinguishes chronic ayahuasca and cannabis users from non-users

    European Neuropsychopharmacology (2026)

    Automatisch synchronisiert

    ID: auto-10-1016-j-euroneuro-2026-112782

    DOI: 10.1016/j.euroneuro.2026.112782

    Zur Quelle

Forensic Science International

1 Quellen
  1. Explainable machine learning to identify cannabinoid 1 receptor agonists

    Forensic Science International (2026)

    Automatisch synchronisiert

    ID: auto-10-1016-j-forsciint-2026-112922

    DOI: 10.1016/j.forsciint.2026.112922

    Zur Quelle

Regional Science and Urban Economics

1 Quellen
  1. The heterogeneous effects of cannabis dispensaries on crime: The importance of foot traffic

    Regional Science and Urban Economics (2026)

    Automatisch synchronisiert

    ID: auto-10-1016-j-regsciurbeco-2026-104220

    DOI: 10.1016/j.regsciurbeco.2026.104220

    Zur Quelle

Social Sciences & Humanities Open

1 Quellen
  1. Harmonizing health logistics: A digital framework for balancing medical cannabis demand and supply

    Social Sciences & Humanities Open (2026)

    Automatisch synchronisiert

    ID: auto-10-1016-j-ssaho-2026-102484

    DOI: 10.1016/j.ssaho.2026.102484

    Zur Quelle

Phytomedicine

1 Quellen
  1. A sesquiterpene-rich essential oil from Cannabis sativa L. attenuates symptoms and neuroinflammation in experimental autoimmune encephalomyelitis model through a CB2-mediated signalling

    Phytomedicine (2026)

    Automatisch synchronisiert

    ID: auto-10-1016-j-phymed-2026-158068

    DOI: 10.1016/j.phymed.2026.158068

    Zur Quelle

Pharmacy & Pharmacology International Journal

1 Quellen
  1. High Stakes Considerations with Medical Marijuana

    Pharmacy & Pharmacology International Journal (2106)

    Automatisch synchronisiert

    ID: auto-10-15406-ppij-2015-03-00058

    DOI: 10.15406/ppij.2015.03.00058

    Zur Quelle